Cannabinoid · Phytocannabinoid
Cannabigerovarin (CBGV) is a phytocannabinoid made by the cannabis plant, in the CBG-type group. Propyl analog of CBG.
Where it fits
Cannabigerovarin (CBGV) derives from CBGVA. See the Phytocannabinoids index for how it relates to the rest of the family.
What the research shows
Direct human research on Cannabigerovarin (CBGV) is minimal; it is characterised mainly by its chemistry and its place in the cannabinoid family rather than by clinical studies. We flag that plainly rather than overstate it.
FAQ
Is CBGV intoxicating? No. Cannabigerovarin (CBGV) is non-intoxicating.
Where does CBGV come from? From CBGVA.
How does CBGV differ structurally from CBG? CBGV has a 3-carbon propyl side chain (C19H28O2) instead of the 5-carbon pentyl side chain of CBG (C21H32O2).
Propyl-Chain (C3H7) Isolation, CBGVA Decarboxylation, and TRP Ion Channel Pharmacology
Cannabigerovarin (CBGV, C19H28O2) is the 3-carbon propyl-side-chain homolog of cannabigerol (CBG), first isolated and structurally identified from Thai Cannabis alongside CBCV by Shoyama et al. (Shoyama et al., 1975, PubMed PMID 1182840). Heating decarboxylates cannabigerovarinic acid (CBGVA) into neutral CBGV according to the decarboxylation temperature chart, and receptor screening demonstrates that CBGV activates and desensitizes TRPV1, TRPV2, and TRPA1 channels while inhibiting cellular anandamide reuptake in vitro (De Petrocellis et al., 2011, PubMed PMID 21175579).
Part of the NOIDS cannabinoids index. Educational reference, not medical advice.